U.S. gives emergency authorization for H7N9 flu test kits

05/9/2013 | New Scientist

The U.S. government, in recognition of the possible threat presented by H7N9 bird flu, has authorized the emergency use of unapproved diagnostic kits that can detect flu genes using a polymerase chain reaction test. The move is intended to hasten the delivery of antiviral drugs and limit the transmission of the virus while vaccines are developed. The next emergency authorization may be for adjuvants, immune-stimulating chemicals that would be put in vaccines.

View Full Article in:

New Scientist

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA